Non-myeloablative conditioning for allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia. The impact of the remission status

Multicentre randomized trials have shown that allogeneic hematopoietic stem cell transplantation (HSCT) is the most effective strategy for preventing relapse in patients in first complete remission (CR) of acute myeloblastic leukemia (AML), offering up to 50% disease-free survival. However in adult...

Descripción completa

Detalles Bibliográficos
Autores principales: Gutiérrez Aguirre, C. H., Cantú Rodríguez, O. G., González LLano, O., Salazar Riojas, R., Martínez González, O. L., Jaime Pérez, J. C., Gómez Almaguer, D.
Formato: Artículo
Lenguaje:English
Publicado: 2005
Materias:
Acceso en línea:http://eprints.uanl.mx/27802/1/492.pdf